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Abstract Cortical networks are characterized by sparse connectivity, with synapses found at
only a subset of axo-dendritic contacts. Yet within these networks, neurons can exhibit high
connection probabilities, suggesting that cell-intrinsic factors, not proximity, determine
connectivity. Here, we identify ephrin-B3 (eB3) as a factor that determines synapse density by
mediating a cell-cell competition that requires ephrin-B-EphB signaling. In a microisland culture
system designed to isolate cell-cell competition, we find that eB3 determines winning and losing
neurons in a contest for synapses. In a Mosaic Analysis with Double Markers (MADM) genetic
mouse model system in vivo the relative levels of eB3 control spine density in layer 5 and 6
neurons. MADM cortical neurons in vitro reveal that eB3 controls synapse density independently of
action potential-driven activity. Our findings illustrate a new class of competitive mechanism
mediated by trans-synaptic organizing proteins which control the number of synapses neurons
receive relative to neighboring neurons.
DOI: https://doi.org/10.7554/eLife.41563.001
Introduction
In the developing brain, neurons must form specific connections in an environment with many poten-
tial synaptic partners while also controlling the number of synapses they receive (Sanes and Yama-
gata, 2009). Defects in the abundance of synaptic connections are associated with devastating
diseases, such as schizophrenia, intellectual disability, and autism (Yin et al., 2012; Zoghbi and
Bear, 2012). The precise number and pattern of contacts only emerge after a period of exuberant
synaptogenesis, which generates an excess of synapses that are then subjected to further refinement
(Williams et al., 2010). However, while synaptic sites are over-produced during development, con-
nectivity is thought to remain sparse, with only a small number of all possible synaptic contacts
made (Druckmann et al., 2014; Song et al., 2005; Stepanyants and Chklovskii, 2005). Indeed,
serial electron microscopic reconstruction of dendritic spines in mouse cortex reveals that each spine
contacts an average of nine different axons, while only forming a synapse with one (Kasthuri et al.,
2015). Since only a small fraction of the possible connections between neurons exist, how do neu-
rons decide whether to accept or reject potential synaptic contacts? Despite the importance of this
question, molecular mechanisms that might enable neurons to specify and control the number of
contacts made remain largely unknown.
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One way to generate the sparse set of contacts found in the brain would be to regulate the num-
ber of contacts each neuron is capable of making relative to its nearby neighbors. The observation
that synapse density varies greatly between neighboring neurons and does not correlate to local
axon density suggests that neurons may physically interview potential synaptic partners, using
molecular cues that control synapse density (Brown and Hestrin, 2009; Chklovskii et al., 2004;
Druckmann et al., 2014; Stepanyants and Chklovskii, 2005). Consistent with a role for such molec-
ular cues, synapse development proceeds normally in the absence of neuronal activity or even neu-
rotransmitter release (Augustin et al., 1999; Sando et al., 2017; Sigler et al., 2017). By defining
how potential synaptic inputs are distributed between neighboring neurons as they develop, molec-
ular cell-contact driven mechanisms could both limit the overall local connectivity and regulate local
variations in synapse density.
Numerous trans-synaptic cell adhesion interactions serve as mediators of synapse formation and
maturation and likely provide for specificity between synaptic partners (Biederer and Stagi, 2008;
Dalva et al., 2007; Lai and Ip, 2009; McMahon and Dı´az, 2011). Trans-synaptic interactions can
coordinate the wiring of individual synapses, but recent evidence suggests that trans-synaptic signal-
ing may also control how many synapses a neuron receives in relation to nearby neurons. Indeed, dif-
ferences in the expression of trans-synaptic adhesion proteins and BDNF/TrkB can control the local
distribution of synaptic inputs (Bian et al., 2015; English et al., 2012; Kwon et al.,
2012; McClelland et al., 2010). These studies suggest that similar to activity-dependent competi-
tion in the developing brain (Katz and Shatz, 1996), neurons may use molecular cues to compete
with one another for synapses. While each of these studies provides some evidence for a molecular
competition, they fail to demonstrate that a molecular competition occurs, since specific winning
and losing neurons cannot be identified in complex in vivo or in vitro systems.
One molecule linked to a competitive mechanism for synapse development is eB3. Relative, but
not absolute levels of eB3 expression regulate excitatory synapse density in cortical neurons, without
affecting inhibitory synapses (McClelland et al., 2010). Thus, Efnb3-/- cortical neurons have normal
synapse density in vitro and in vivo but generate fewer synaptic contacts when co-cultured with wild
type neurons at a 1:10 ratio. Likewise, wild type neurons co-cultured with eB3 null neurons at a 1:10
ratio have higher than normal synapse density (McClelland et al., 2010) . Consistent with these find-
ings, shRNA knockdown of eB3 using low-efficiency transfection methods also reduces synapse den-
sity in vitro (McClelland et al., 2010).
The above results led us to propose a model in which post-synaptic eB3 acts as a competitive sig-
nal that enables neurons with higher eB3 levels to generate more synapses. For what are neurons
competing? Ephrin-B3 can regulate synapse density through a trans-synaptic interaction with pre-
synaptic EphB2 (McClelland et al., 2010), suggesting that neurons might compete for EphB2. In this
model, higher eB3 expression gives neurons an advantage to more effectively compete for binding
of EphB2 found in axons. Based on this neuron-neuron competition model we predict that: 1) rela-
tive differences in eB3 expression levels between two neurons should generate a winning (more eB3)
and a losing (less eB3) neuron with higher and lower synaptic density respectively, without altering
the total number of synapses received by the two neurons; and 2) blocking or preventing interac-
tions between eB3 and EphB2 should nullify the competitive signaling, leading to equal synapse
density regardless of the level of eB3 in each post-synaptic neuron.
Here, using a combination of approaches, including a two-neuron microisland cortical neuron cul-
ture system that allows assignment of winners and losers in a competition for synapses, we demon-
strate that neurons use eB3 to compete for pre-synaptic EphBs. Using the Mosaic Analysis with
Double Markers (MADM) genetic mouse model we show that relative levels of ephrin-B3 regulate
dendritic spine density in layer 5 and 6 pyramidal neurons in vivo. Remarkably, control of local syn-
apse density by eB3 persists in the absence of action potential-driven activity, suggesting that eB3-
mediated competition functions independently of activity-dependent mechanisms in cultured cortical
pyramidal neurons. Together these results define eB3 as a trans-synaptic signal that is not required
for synapse formation but instead controls the local distribution of a limited pool of synapses by
competing for EphBs.
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Results
Ephrin-B3 does not regulate synapse density in a non-competitive
environment
Our previous findings in complex cortical neuron cultures and in vivo suggest a model in which post-
synaptic eB3 regulates synapse density through a molecular contest for pre-synaptic EphBs
(McClelland et al., 2010). However, the complexity of these systems precludes testing of the
hypothesis that eB3 directs a molecular competition for synaptic inputs between adjacent neurons.
To address whether relative differences in eB3 expression between identified neurons control a com-
petition for synaptic inputs, we utilized a microisland cortical culture system (Allen, 2006; Tarsa and
Goda, 2002) (Figure 1—figure supplement 1). We generated two types of islands: one containing
a single neuron, and a second containing two neurons. Unlike previous studies in vivo, in brain slice,
or in culture (Bian et al., 2015; English et al., 2012; Kwon et al., 2012; McClelland et al., 2010),
each microisland is a closed system, enabling neurons to be isolated without the opportunity to
compete (single-neuron system), or providing for direct competition between identifiable neurons
(two-neuron system). Moreover, the simplified nature of the microisland system allows the essential
aspect of a competition to be observed: a winner and a loser. We expect that if eB3 directs a con-
test for synapses between neighboring neurons, eB3 knockdown in single-neuron microislands
should have no effect on synapse density since competition cannot occur. In contrast, knockdown of
eB3 in one neuron within a two-neuron microisland should reduce this neuron’s ability to compete.
Thus, if eB3 regulates a competition for synapses, these two-neuron doublets should generate a
‘loser’, the neuron with reduced eB3, with lower synapse density and a ‘winner’, the untransfected
neuron, with higher synapse density, without changing the total density of synapses in the
microisland.
To test these hypotheses, we first generated single-cortical neuron microisland cultures and
knocked down eB3 expression with a lentivirus containing a previously characterized eB3 shRNA
that selectively reduces eB3 expression by at least 50% (Figure 1) (McClelland et al., 2010). We
then quantified synapse density by fixing and immunostaining cultures for pre- and post-synaptic
markers (vGlut1 and PSD-95, respectively), a method which we have shown detects decreases in syn-
apse number following eB3 knockdown as confirmed by a concomitant reduction in mEPSC fre-
quency (McClelland et al., 2010). In these single-neuron microislands, synapse density should be
unaffected by changes in eB3 expression level. As expected, synapse density in neurons transduced
with GFP and either eB3 shRNA or control virus were not significantly different (Figure 1c,d). Thus,
in conditions where cell-cell competition cannot occur, eB3 does not regulate synapse density or the
ability of neurons to form synapses.
PSD-95-GFP reliably localizes to synapses and does not alter synapse
number
Knockdown of eB3 or mixing eB3 null neurons with wild-type neurons at a 1:10 ratio results in
reduced synapse density in cells within complex neuronal cultures (McClelland et al., 2010). To test
whether this results from a failure of neurons expressing low levels of eB3 to compete for synapses,
the levels of eB3 in one neuron within a two-neuron microisland were reduced and the effects on
synapse density of both neurons in the microisland determined. In order to distinguish synaptic con-
tacts onto the transfected neuron from those onto the transfected neuron within microisland dou-
blets, we developed a Gateway compatible expression construct (Fisher Scientific) expressing PSD-
95-GFP and cell filling tdTomato from two distinct mammalian promoters. In addition, this vector
expressed either eB3 shRNA (pFUGW-tdTomato-eB3.2) or pSuper control (pFUGW-tdTomato-
pSuper) from a separate promoter. Using this construct, we found that PSD-95-GFP reliably localized
to post-synaptic sites and could be effectively used to determine the density of synapses onto trans-
fected neurons (Figure 2a–c). Importantly, with our transfection conditions the expression of PSD-
95-GFP did not alter the density of synapses onto neurons in either single- or two-neuron microis-
lands (Figure 2d and Figure 3). It should be noted that although expression of PSD-95-GFP to mark
post-synaptic specializations did not alter synapse density in our culture system, any potential
increase in synapse number caused by PSD-95-GFP expression would only be expected to lessen
the effect of eB3 shRNA expression within competitive doublets, since eB3 shRNA and PSD-95-GFP
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were expressed in the same cell. Thus, this approach is well suited to examine whether eB3 regulates
the ability of individual neurons to compete for pre-synaptic contacts. Consistent with the results of
eB3 knockdown using lentiviral transduction (Figure 1), expression of eB3 shRNA combined with
PSD-95-GFP did not affect synapse density in single-neuron microislands (Figure 2d).
Figure 1. Knockdown of ephrin-B3 does not alter synapse density in single-neuron microislands. (a and b) Representative images of dendrites from
single-neuron microislands transduced with control (pSuper) and eB3 shRNA viruses and immunostained at DIV21 for vGlut1 and PSD-95. Scale bar, 20
mm. (c) Higher magnification images of boxed regions shown in a and b. Arrowheads indicate colocalized vGlut1 and PSD-95 puncta. Scale bar, 5 mm.
(d) Quantification of synapse density in single neuron microislands (Control, n=27; eB3 shRNA, n=47; t(72)=0.9390, p=0.3509, two-tailed Student’s t-test)
transduced with the indicated viruses.
DOI: https://doi.org/10.7554/eLife.41563.002
The following source data and figure supplement are available for figure 1:
Source data 1. Knockdown of ephrin-B3 does not alter synapse density in single-neuron microislands.
DOI: https://doi.org/10.7554/eLife.41563.003
Figure supplement 1. Schematic of microisland experimental design.
DOI: https://doi.org/10.7554/eLife.41563.004
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Ephrin-B3 directs a molecular competition for synapses in microislands
We next generated control microislands in which we expect that neurons would have no consistent
competitive advantage in forming synapses by combining two neurons with endogenous levels of
eB3 expression in a single microisland (Figure 3a,b). To do this, we transfected neurons by electro-
poration in suspension with our PSD-95-GFP control construct (pFUGW-tdTomato-pSuper). Two-cell
Figure 2. PSD-95-GFP localizes to synapses and does not alter synapse density. (a and b) Representative images of single-neuron microislands
transfected with the indicated constructs and immunostained for GFP (for PSD-95-GFP), PSD-95 and vGlut1. Boxed regions are shown in enlarged
insets. Scale bars represent 20 mm in merged images and 5 mm in insets. (c) Comparison of synapse density quantification in single neuron microislands
using PSD-95 or GFP immunostaining for PSD-95-GFP (n = 18 cells; t(34)=0.08148, p=0.9355, two-tailed Student’s t-test). (d) Quantification of synapse
density in single neurons transfected with the indicated constructs using PSD-95 and vGlut1 immunostaining (Untransfected, n = 20; PSD-95-GFP,
n = 18; PSD-95-GFP + eB3 shRNA, n = 18; F(2,53)=.1008, p=0.9043, one-way ANOVA).
DOI: https://doi.org/10.7554/eLife.41563.005
The following source data is available for figure 2:
Source data 1. PSD-95-GFP localizes to synapses and does not alter synapse density.
DOI: https://doi.org/10.7554/eLife.41563.006
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Figure 3. Synapse density is regulated by an ephrin-B3-dependent competitive mechanism. (a) Representative images of control and competitive
doublets. Neurons were immunostained for vGlut1, PSD-95 and GFP (for PSD-95-GFP) at DIV21. Arrows indicate untransfected (white arrow) and
transfected (green arrow) neurons. Scale bar, 20 mm. (b) Higher magnification images of the boxed regions shown in a. Arrowheads indicate examples
of colocalized puncta. Scale bar, 5 mm. (c and d) Scatter plots in which the x and y coordinates of each point respectively represent synapse density in
transfected and untransfected neurons within a doublet pair. The red point in each graph represents the average of all data points. (e) Quantification of
the fraction of total synapse density on neurons within control and competitive doublets (control doublets, n=25 for untransfected and PSD-95-GFP
cells; competitive doublets, n=53 for untransfected and eB3 shRNA cells; F(3,152)=23.12, p<0.0001, one-way ANOVA *P<0.05,****P<0.0001 Tukey’s
post hoc. (f) Quantification of total synapse density in doublets (control doublets, n=25; competitive doublets n=53; t(76)=.01448, p=0.9882, two-tailed
Student’s t-test). (g) Schematic of the microisland doublet experiment. Black and green neurons indicate untransfected and transfected neurons,
respectively. Synapses are represented as black dots.
Figure 3 continued on next page
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microislands were generated when one transfected and one untransfected neuron landed on the
same island as the neurons were plated. At day in vitro (DIV) 21 we quantified synapse density in
two-neuron microislands by immunostaining for synaptic markers (Figure 3b). We have shown previ-
ously that expression of eB3 varies between neurons and eB3 levels positively correlate with synapse
density (McClelland et al., 2010). Therefore, we expected that neither the transfected or untrans-
fected cell would consistently have more synapses, but that one neuron in each pair of cells might
have more synapses than the other. To capture variation between individual cells, we plotted syn-
apse density in untransfected vs. control (PSD-95-GFP) transfected neurons on a scatter plot such
that each data point represents two cells within a single microisland pair (Figure 3c). Synapse den-
sity was typically higher in one neuron within each pair (Figure 3c, dashed line represents equal syn-
apse density), but there was no bias in whether the transfected or untransfected neuron won.
Accordingly, untransfected and transfected cells in these control doublets received an equal propor-
tion of synapses within the doublets on average, indicating that synapses were equally distributed
among neurons.
Next, we created a situation with reliable differences in eB3 levels with the expectation that a
consistent winning and losing neuron would emerge. Neurons were transfected with our eB3 knock-
down construct (pFUGW-tdTomato-eB3.2) and microislands were created by transfected and
untransfected neurons that landed on individual islands (Figure 3a,b). In competitive doublets where
eB3 was knocked down in one of the two neurons, eB3 shRNA transfected cells received a signifi-
cantly lower proportion of total synaptic contacts than untransfected cells, and a significantly lower-
proportion of synaptic contacts than transfected and untransfected cells in control doublets
(Figure 3d,e). Likewise, untransfected cells received a higher proportion of synapses within competi-
tive doublets, and a higher proportion of synapses than untransfected and transfected cells in con-
trol doublets (Figure 3d,e). Thus, in a single two-neuron microisland, a higher relative level of eB3 in
a cell provides a competitive advantage, generating a winner in a competition for synaptic inputs.
Neurons within microisland doublets have a broad range of synapse densities (Figure 3c,d). Despite
this variation, examination of competitive doublets shows that neurons with endogenous levels of
eB3 (untransfected) consistently emerged as winners (83% of doublets). In contrast, control trans-
fected cells were winners much less often (83% vs. 44%, Competitive vs. Control p=0.001, Fisher’s
exact test). There was a ~ 35% increase in synapse density in untransfected neurons compared to
eB3 knockdown neurons within the same competitive doublet (mean difference, untransfected cell-
transfected cell, n = 53 doublets, 8.05 ± 1.48 synapses/100 mm, p<0.0001, one-sample t-test), while
no such difference was observed in control doublets (n = 25 doublets, 0.15 ± 2.18 synapses/100 mm,
p=0.994, one sample t-test). Total synapse density in competitive doublets in which one neuron
expressed eB3 shRNA was unchanged from that of control doublets (Figure 3f). This indicates that
knockdown of eB3 did not alter the overall number of synapses that the pair of neurons could form.
Rather, knockdown of eB3 results in a redistribution of synapses onto neurons with higher eB3
expression (winners) at the expense of neurons that were transfected with eB3 shRNA (losers). These
results suggest that eB3 functions as a cell-cell competition signal that controls how a limited pool of
synaptic inputs is distributed between neurons (Figure 3g).
Ephrin-B3 competes for EphBs
What might be controlling the pool of synaptic inputs neurons can receive? We have previously dem-
onstrated that knockdown of pre-synaptic EphB2 completely blocks the ability of eB3 to induce pre-
synaptic differentiation in a heterologous cell synapse induction assay, suggesting that pre-synaptic
EphB2 is required in this system (McClelland et al., 2010; Scheiffele et al., 2000). Consistent with
this finding, biochemical fractionation revealed that EphB2 is localized to pre-synaptic active zones,
though not exclusively (Bouvier et al., 2008). We, therefore, hypothesized that neurons are
Figure 3 continued
DOI: https://doi.org/10.7554/eLife.41563.007
The following source data is available for figure 3:
Source data 1. Synapse density is regulated by a competitive mechanism.
DOI: https://doi.org/10.7554/eLife.41563.008
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competing for pre-synaptic EphBs. In this model, higher levels of eB3 expression would enable a cell
to out-compete neighboring cells for axonal contacts expressing EphBs, leading to higher synapse
density. This model predicts that preventing the interaction between eB3 and EphBs should nullify
the competitive advantage conferred by higher levels of eB3 expression, preventing these cells from
competing for EphB-expressing axons and thereby rescuing synapse density in neurons with reduced
eB3 to control levels. To block the interaction between eB3 and endogenous EphBs, we applied
unclustered EphB2 ectodomain that binds ephrin-Bs but does not activate ephrin-B signaling
(San Miguel et al., 2011). In the context of eB3 knockdown, we expected that EphB2 ectodomain
would functionally eliminate differences in eB3 expression between cells expressing eB3 shRNA and
the surrounding untransfected cells by preferentially binding to cells expressing wild-type levels of
eB3. To confirm that binding of EphB2 ectodomain is reduced in cells expressing eB3 shRNA, we
first transfected E17-18 rat cortical neurons at DIV0 with EGFP and either eB3 shRNA or control vec-
tor (McClelland et al., 2010). We then applied EphB2 ectodomain for 45 min at DIV10, fixed the cul-
tures, and stained for exogenously applied EphB2 ectodomain (Figure 4—figure supplement 1a,b).
As expected, EphB2 ectodomain puncta density and size were reduced in neurons expressing eB3
shRNA compared to control neurons (Figure 4—figure supplement 1c,d). In addition, we confirmed
that unclustered EphB2 ectodomain does not activate ephrin-B signaling (Figure 4—figure supple-
ment 1e).
We next tested our hypothesis that applying exogenous EphB2 ectodomain in this manner would
nullify the competitive advantage of high eB3 expression, rescuing synapse density in neurons
expressing eB3 shRNA. After transfecting neurons with GFP and either eB3 shRNA or control vector
as described above, we treated cultures from DIV3-10 with EphB2 ectodomain, fixed the neurons at
DIV10 and determined synapse density by immunostaining for PSD-95 and vGlut1. Knockdown of
eB3 in these complex cortical neuron cultures significantly reduced synapse density (Figure 4a,b).
Remarkably, treatment with unclustered EphB2 ectodomain rescued this reduction in synapse den-
sity to control levels (Figure 4a,b). Consistent with the competition model, the rescue of synapse
density by treatment with EphB2 ectodomain was dose-dependent (Figure 4b). The effects of
EphB2 ectodomain were specific to cultures containing neurons with reduced eB3 expression, since
treatment of control-transfected neurons with EphB2 ectodomain had no effect on synapse density
(Figure 4b). These findings suggest that control of synapse density by eB3 relies on relative differen-
ces in eB3 expression, which allow cells to compete for binding of EphBs. As eB3 requires EphB2 in
axons to initiate pre-synaptic differentiation, eB3 likely allows cells to compete for axonal EphB2
(McClelland et al., 2010).
We asked whether we could prevent neurons in competitive microislands from winning or losing
by adding unclustered EphB2 ectodomain. Control and competitive two-neuron microislands were
generated as described above and treated with EphB2 ectodomain from DIV3-21 to block the com-
petition for EphBs (Figure 4—figure supplement 2). Unclustered EphB2 ectodomain treatment did
not affect synapse density in control doublets (EphB2 ectodomain treated doublets, n = 14 neurons,
22.4 ± 1.5 synapses/100 mm vs. untreated doublets, n = 50 neurons, 25.6 ± 1.2 synapses/100 mm, t
(62)=1.305, p=0.1966, two-tailed Students t-test). However, EphB2 ectodomain treatment
completely blocked competition in competitive microislands, preventing both the increase in the
winning (untransfected) and losing (eB3 shRNA transfected) neurons (Figure 4—figure supplement
2c,d). These findings indicate that eB3 likely establishes synapse density through local neuron-neu-
ron competition for pre-synaptic EphBs.
Relative levels of ephrin-B3 determine spine density in vivo
To further characterize the role of eB3 in the competition for synapses in vivo, we sought a genetic
approach. To this end, we generated eB3 Mosaic Analysis with Double Markers (MADM) mice (Fig-
ure 5—figure supplement 1) (Espinosa et al., 2009; Hippenmeyer et al., 2010; Zong et al.,
2005). This model allowed us to study competitive interactions within a genetically defined popula-
tion of WT (Wild type) and Efnb3-/- neurons derived from single animals, identifiable by expression
of different fluorescent markers. By crossing MADM-11 mice, which contain the MADM TG and GT
cassettes on chromosome 11 (Hippenmeyer et al., 2010) to a previously characterized transgenic
mouse containing a null version of the Efnb3 gene on chromosome 11 (Hruska et al., 2015;
McClelland et al., 2010; Yokoyama et al., 2001), we generated mosaic eB3 knockout MADM mice.
We generated two different eB3 MADM lines: one with Emx1-Cre which drives expression of Cre
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Figure 4. Effects of ephrin-B3 knockdown are rescued by unclustered EphB2 ectodomain treatment. (a) DIV10 cortical neurons transfected with the
indicated constructs along with GFP and treated with unclustered EphB2 ectodomain (EphB2-ecto). Arrowheads indicate colocalized PSD-95 (red) and
VGlut1 (blue) puncta along GFP-labeled dendrite. (b) Quantification of colocalized PSD-95 and VGlut1 puncta density (Control/ctrl, n = 22; ctrl/B2-Fc
250 ng n = 19; eB3 shRNA/ctrl, n = 38; eB3 shRNA/B2-Fc 2.5 ng, n = 25; eB3 shRNA/B2-Fc 25, ng n = 22; eB3 shRNA/B2-Fc 250 ng, n = 26; F (5,146)
=8.454, p<0.0001, one-way ANOVA, **p<0.01 (c) Model of the effect of unclustered EphB2 ectodomain treatment on adjacent neurons within complex
cultures. Black dots represent synapses.
DOI: https://doi.org/10.7554/eLife.41563.009
The following source data and figure supplements are available for figure 4:
Source data 1. Effects of ephrin-B3 knockdown are rescued byEphB2 ectodomain.
DOI: https://doi.org/10.7554/eLife.41563.010
Figure supplement 1. Validation of unclustered EphB2 ectodomain treatment method.
DOI: https://doi.org/10.7554/eLife.41563.011
Figure supplement 1—source data 1. Validation of EphB2 ectodomain treatment method.
Figure 4 continued on next page
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recombinase in progenitors of excitatory forebrain neurons (Beattie et al., 2017; Gorski et al.,
2002), and another line with Nestin-Cre that drives expression of Cre recombinase in all neural pro-
genitors but results in much sparser labeling (Nestin-spCre) (Materials and methods)
(Hippenmeyer et al., 2010; Zong et al., 2005). In both lines, sparse recombination generated fluo-
rescently labeled neurons in cortex with known eB3 genotype. In the Wild type MADM (control
MADM) all labeled and unlabeled cells are WT. While in the eB3 mosaic MADM mice,
tdTomato +cells are WT, EGFP +cells are Efnb3-/-, while double labeled tdTomato+/EGFP+ (yellow)
cells and unlabeled cells are Efnb3+/- (Figure 5—figure supplement 1).
We next sought to determine whether eB3 controls spine number in vivo by comparing the den-
sity of dendritic spines on cortical pyramidal neurons of WT (tdTomato+) and Efnb3-/- (EGFP+) neu-
rons within the mosaic eB3 MADM mouse. For this experiment, we chose to use our Nestin-spCre
MADM line, which exhibits sparse labeling, facilitating spine density quantification. Since labeling in
MADM mice is sparse, each WT neuron should have a competitive advantage over the surrounding
unlabeled Efnb3+/- neurons, resulting in an elevated spine density in WT tdTomato + neurons. In
contrast, each Efnb3-/- neuron should be at a competitive disadvantage and receive fewer synapses,
resulting in a lower spine density in Efnb3-/-EGFP + neurons. Finally, double labeled Efnb3+/- (EGFP
+/tdTomato+) neurons should exhibit spine densities in between that of WT and Efnb3-/- cells.
We previously generated and characterized an antibody that recognizes a specific phosphory-
lated serine residue (serine 332) near the C terminus of eB3. In brain sections, we observed high
immunoreactivity in large apical dendrites of sub-granular layer 5 and 6 pyramidal neurons
(Hruska et al., 2015). We hypothesized that these eB3-expressing cells with thicker apical dendrites
may be thick-tufted projection neurons that express the marker CTIP2 (Chen et al., 2008;
Leone et al., 2015). These neurons are known to be larger than callosally projecting (SATB2+) neu-
rons. To test this, we used three color RNAscope in situ hybridization (ISH) to assess the expression
of eB3 mRNA (Efnb3) in subgranular neurons expressing CTIP2 mRNA (Bcl11b) and SATB2 mRNA
(Satb2) alone or in conjunction (Anderson et al., 2016; Ataman et al., 2016; Harb et al., 2016) (Fig-
ure 5). Both CTIP2 + and CTIP2+/SATB2 + cells expressed higher levels of Efnb3 than SATB2 + cells
(Figure 5a,b). The low level of RNAscope signal for Efnb3 in SATB2 + neurons was the same as
found in Efnb3-/- mice (Hruska et al., 2015; Yokoyama et al., 2001) (Figure 5—figure supplement
2), suggesting that SATB2 + cells may not express eB3.
Consistent with this, in Efnb3-/- cells, we found a significant reduction in eB3 signal in CTIP2 + cells
that were indistinguishable from Efnb3 levels in WT SATB2 + neurons, while no additional decrease
in eB3 mRNA levels was observed in SATB2 + cells (Figure 5—figure supplement 2). Thus, we
hypothesized that loss of eB3 would reduce synapse density in CTIP2 + layer 5 and 6 neurons, leav-
ing neighboring SATB2 + neurons unaffected.
To determine whether we could distinguish CTIP2 and SATB2 expressing neurons based on their
morphology, we stained control and eB3 MADM brain sections for CTIP2 and SATB2 (Figure 5c)
(Alcamo et al., 2008). Consistent with previous findings, we found that the apical dendrites of
CTIP2 + neurons were significantly thicker than those of CTIP2-/SATB2 + neurons, with most of
them exceeding 1.6 mm in diameter (CTIP2+, n = 31; CTIP2-/SATB2+, n = 12; 2.04 ± 0.10 vs.
1.57 ± 0.08 mm; t(41)=2.697, p=0.0101, two-tailed Student’s t-test) (Chen et al., 2008;
Oswald et al., 2013) (Figure 5d). In contrast, most CTIP2-/Satb2 + neurons were less than 1.6 mm in
diameter (Figure 5d). We next asked whether eB3 expression varied within the population of
CTIP2 + thick apical dendrite neurons. Using RNAscope, we found that Efnb3 expression varied > 4
fold in CTIP2 + cells (Figure 5—figure supplement 2). Together with results from RNAscope, these
data suggest that within layers 5 and 6, differences in eB3 expression levels might have selective
effects in CTIP2 + subcortically projecting neurons with thick apical dendrites.
Figure 4 continued
DOI: https://doi.org/10.7554/eLife.41563.012
Figure supplement 2. Unclustered EphB2 ectodomain blocks competition in microislands.
DOI: https://doi.org/10.7554/eLife.41563.013
Figure supplement 2—source data 1. EphB2 ectodomain blocks competition in microislands.
DOI: https://doi.org/10.7554/eLife.41563.014
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Figure 5. Efnb3 is expressed in CTIP2 +projection neurons. (a) Representative cells within WT mouse cortex labeled by RNAscope ISH for CTIP2 mRNA
(Bcl11b), SATB2 mRNA (Satb2), and eB3 mRNA (Efnb3). Scale bar, 3 mm. (b) Quantification of the number of RNAscope ISH eB3 puncta per cell across
the indicated cell types (CTIP2+, n = 72; CTIP2+/SATB2+, n = 69; SATB2+, n = 93; F (2, 231)=9.332, p=0.0001, one-way ANOVA, ***p=0.0004,
**p=0.0026 *, Tukey’s post hoc.) (c) Representative image of a tdTomato+/CTIP2 +cell in MADM cortex co-labeled with CTIP2 and SATB2 antibodies.
Scale bar, 10 mm. (d) Analysis of apical dendrite width in subgranular neurons expressing CTIP2 and/or SATB2. Most neurons expressing CTIP2 have
large (>1.6 mm) dendrites.
DOI: https://doi.org/10.7554/eLife.41563.015
Figure 5 continued on next page
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To begin to test this, we quantified the density of dendritic spines on the apical dendrites of sub-
granular layer 5 and 6 neurons in MADM animals. In control MADM mice, we observed no differen-
ces in average spine density between EGFP+, tdTomato+, or EGFP+/tdTomato+ (yellow) cells
(Figure 6—figure supplement 1). Thus, we grouped these three populations of cells for further anal-
yses. In eB3 MADM mice, no differences in average spine density were observed in cells with thin
apical dendrites (<1.6 mm) (Figure 6c,d). In contrast, neurons with thick apical dendrites in eB3
MADM mice, WT (tdTomato+) neurons had significantly higher spine density than WT neurons from
control MADM mice, Efnb3-/- (EGFP+) neurons (~38% increase) and Efnb3+/- neurons (~21%
increase, Figure 6a,b). Consistent with the finding that expression levels of eB3 linearly correlate
with synapse density (McClelland et al., 2010), the average density of spines on Efnb3+/- GFP+/
tdTomato+) neurons was in between that of WT and Efnb3-/- neurons (Figure 6a,b). Together, with
our RNAscope data these results support a model where the relative levels of eB3 in
CTIP2 + subgranular neurons functions to competitively regulate spine density.
Ephrin-B3 controls synapse number in pyramidal neurons of defined
genotypes
Ephrin-B3 regulates spine density in a competitive fashion in layer 5 and 6 neurons in eB3 MADM
mice. To test whether synapse density is regulated in a similar manner, we used a simplified culture
system. We generated cultures of genetically defined neurons by dissociating cortices of eB3
MADM (heterogenotypic cultures) or control MADM (control cultures) mice at P0 and used FACS to
isolate EGFP + and tdTomato + cells (Figure 7a,b). We used our Emx1-Cre eB3 MADM line for this
experiment due to the higher density of labeled cells, which increased the yield of FACS-purified
cells.
To maximize the opportunity for competition between WT (tdTomato+) and Efnb3-/- (EGFP+)
cells, we plated tdTomato + and EGFP + cells at a 1:1 ratio (Figure 7b,c). At DIV11, the cultures
were fixed and stained for the excitatory synaptic marker vGlut1. We then took an unbiased imaging
approach in which a confocal microscope was set to image each culture in its entirety in sequential
150  150 mm image fields using image tiling (Figure 7d) (Materials and methods). To test whether
WT cells exhibit a competitive advantage over nearby Efnb3-/- cells for synaptic contacts in MADM
cultures, we quantified the density of vGlut1 + synapses onto WT and Efnb3-/- cells in each 150 
150 mm image field, and asked whether WT cells received a disproportionate pool of these synaptic
contacts. In Control MADM cultures, in which EGFP + and tdTomato + cells were both WT, we
found no significant difference in synapse density between tdTomato + and EGFP + cells (n = 218
fields, 25.2 ± vs 22.6 ± 1.3 vGlut1 puncta/1000 mm2, t(434)=1.463, p=0.1443, two-way Student’s
t-test) (Figure 8a,c). However, in heterogenotypic MADM cultures containing WT (tdTomato+) and
Efnb3-/- (EGFP+) cells, WT cells exhibited higher synapse density than Efnb3-/- cells (n = 108 fields,
32.5 ± 1.6 vs 25.0 ± 1.4, t (214)=3.527, p=0.0005, two-tailed Student’s t-test) (Figure 8b,d). More-
over, the proportion of fields in which tdTomato + cells received more synaptic contacts was signifi-
cantly higher than in control cultures (70% vs. 57%, p=0.0216, Fisher’s exact test) (Figure 8c,d). The
total density of synapses was not significantly different between control and heterogenotypic cul-
tures (control cultures, n = 3; heterogenotypic cultures, n = 3; 23.19 ± 1.2 vs. 26.35 ± 4.43 vGlut1
puncta/1000 mm2; t(4)=0.6866, p=0.5301, two-tailed Student’s t-test). These results show that eB3
Figure 5 continued
The following source data and figure supplements are available for figure 5:
Source data 1. Efnb3 is expressed in CTIP2 +projection neurons.
DOI: https://doi.org/10.7554/eLife.41563.016
Figure supplement 1. Schematic of recombination in eB3 MADM mice.
DOI: https://doi.org/10.7554/eLife.41563.017
Figure supplement 2. Controls for RNAscope ISH.
DOI: https://doi.org/10.7554/eLife.41563.019
Figure supplement 2—source data 1. Controls for RNAscope ISH.
DOI: https://doi.org/10.7554/eLife.41563.020
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controls synapse density in a competitive manner in a genetically defined population of WT and
Efnb3-/- excitatory pyramidal neurons.
Ephrin-B3-mediated competition does not require neuronal activity
To determine whether competitive interactions between WT and Efnb3-/- neurons derived from eB3
MADM mice are dependent on action potential-driven activity. We treated control or heterogeno-
typic MADM cultures with tetrodotoxin (TTX) to block action potential-driven neuronal activity from
DIV3-11, fixed and immunostained the cultures for vGlut1, and determined synapse density as
Figure 6. Relative levels of ephrin-B3 control spine density in vivo. (a) Representative large diameter (>1.6 mm) dendrites of subgranular pyramidal
neurons in control and eB3 Nestin-spCre MADM mice. Scale bar, 3 mm. (b) Representative small diameter (<1.6 mm) dendrites of subgranular pyramidal
neurons in control and eB3 Nestin-spCreMADM mice. (C) Quantification of spine density on large diameter dendrites from neurons in control and eB3
MADM mice (control MADM (WT), n=93; eB3 MADM tdTomato+ (WT), n=50; eB3 MADM tdTomato+/EGFP+ (Efnb3+/-), n=24; eB3 MADM EGFP+
(Efnb3-/-), n= 38; F(3, 201)= 10.40, p<0.0001, one-way ANOVA, ****p<0.0001, ***p=0.0011 *p<0.05, Tukey’s post hoc.) ( d) Quantification of spine
density on small diameter dendrites from neurons in control and eB3 MADM mice (control MADM, n=48; eB3 MADM TdTomato+ (WT), n=19; eB3
MADM EGFP+ (Efnb3-/-), n= 33; F(2, 97)= 1.283, p=0.2818, one-way ANOVA).
DOI: https://doi.org/10.7554/eLife.41563.021
The following source data and figure supplements are available for figure 6:
Source data 1. Relative levels of ephrin-B3 control spine density in vivo.
DOI: https://doi.org/10.7554/eLife.41563.022
Figure supplement 1. Equal spine density in control MADM neurons regardless of fluorophore expressed.
DOI: https://doi.org/10.7554/eLife.41563.023
Figure supplement 1—source data 1. Spine density WT MADM neurons.
DOI: https://doi.org/10.7554/eLife.41563.024
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described above. As expected, synapse density in each image field did not differ between
tdTomato + and EGFP + cells in control cultures treated with TTX (n = 166 fields, 25.3.3 ± 1.1 vs
23.1 ± 1.0 vGlut1 puncta/1000 mm2, t(330)=1.433, p=0.1528, two-tailed Student’s t-test) (Figure 9a,
c). In agreement with other work (Harms and Craig, 2005; Sigler et al., 2017), we did not observe
any changes in total synapse density between untreated and TTX-treated control MADM cultures
(untreated, n = 3 cultures; TTX treated, n = 3 cultures; 23.19 ± 1.2 vs. 22.57 ± 3.41 vGlut1 puncta/
1000 mm2; t(4)=0.1715, p=0.8722, two-tailed Student’s t-test). If eB3-dependent competition
requires action potential-driven neuronal activity, we would expect that in heterogenotypic cultures
TTX treatment should block WT (tdTomato+) neurons from winning the competition for synaptic
contacts, rescuing the system back to the control condition. In TTX-treated heterogenotypic cultures
WT (tdTomato+) cells still received a higher density of vGlut1 + contacts than Efnb3-/- (EGFP+) cells
(n = 135 fields, 29.8 ± 1.8 vs. 22.9 ± 1.7 vGlut1 puncta/1000 mm2, t(268)=2.772, p=0.006, two-tailed
Student’s t-test) (Figure 9b,d), while the total density of synapses was not different from TTX-
treated control MADM cultures (control cultures, n = 3; heterogenotypic cultures, n = 3;
22.57 ± 3.41 vs. 19.97 ± 7.28 vGlut1 puncta/1000 mm2, t(4)=0.3234, p=0.7626, two-tailed Student’s
t-test). Moreover, in heterogenotypic cultures treated with TTX the proportion of fields with more
Figure 7. Use of ephrin-B3 MADM mice to generate heterogenotypic cultures. (a) Representative image of eB3 MADM (Emx1-Cre line) cortex
containing sparse EGFP +and/or tdTomato +expressing cells. Scale bar, 100 mm. (b) Workflow diagram for generating eB3 MADM cultures. (c)
Representative image of a control eB3 MADM culture. Scale bar, 300 mm. (d) Representative single image field and processed image mask used for
synapse density analysis. Scale bar, 15 mm.
DOI: https://doi.org/10.7554/eLife.41563.025
Henderson et al. eLife 2019;8:e41563. DOI: https://doi.org/10.7554/eLife.41563 14 of 29
Research article Neuroscience
Figure 8. Ephrin-B3 regulates local cell-cell differences in synapse density in MADM cultures. (a and b) Representative image fields and corresponding
masks used for analysis from control (a) and heterogenotypic (b) DIV11 MADM cultures. Scale bar, 20 mm. (c and d) Scatter plots in which each point
represents the density of vGlut1+ synapses contacting tdTomato+ (y axis) and EGFP+ (x axis) neurons in a single image field. The red point in each
graph represents the average of all data points. The proportion of fields in which tdTomato+ neurons received a higher fraction of local synaptic
contacts than EGFP+ neurons is significantly higher in heterogenotypic cultures than control cultures (control, n= 218 fields; heterogenotypic, n=108
fields; p=0.0216, Fisher’s exact test).
DOI: https://doi.org/10.7554/eLife.41563.026
The following source data is available for figure 8:
Figure 8 continued on next page
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synaptic contacts onto WT tdTomato + cells was significantly higher in than in control cultures (74%
vs. 58%, p=0.0036, Fisher’s exact test) (Figure 9c,d). Similar to control MADM cultures, TTX treat-
ment did not significantly change the total density of synapses in heterogenotypic cultures
(untreated cultures, n = 3, TTX-treated cultures, n = 3, 26.35 ± 4.43 vs. 19.97 ± 7.28 vGlut1 puncta/
1000 mm2, t(4)=0.748, p=0.496, two-tailed Student’s t-test). Thus, eB3-mediated competition for syn-
aptic inputs persists in the absence of action potential-driven neuronal activity, suggesting that the
eB3-EphB competition may function upstream of neuronal activity.
Discussion
Here, we find that a trans-synaptic organizing molecule, eB3 mediates a cell-cell competition for
EphBs that regulates the density of synapses onto cortical neurons. This is supported by three find-
ings: 1) relative differences in eB3 control the distribution of pre-synaptic inputs between isolated
pairs of cells without altering total synapse density (Figure 3), 2) relative levels of eB3 control spine
density in vivo (Figure 6), and 3) addition of exogenous EphB2 prevents eB3-dependent competition
(Figure 4). Further supporting the competition model, neurons that lack eB3 have no synapse den-
sity phenotype when cultured with other neurons lacking eB3. However, when challenged with wild-
type eB3 expressing neurons, these cells have significantly fewer synapses (Figure 8)
(McClelland et al., 2010). Thus, analogous to activity-dependent competition that is important for
critical period plasticity of ocular dominance and orientation selectivity in visual cortex (Katz and
Shatz, 1996), eB3 appears to regulate a molecular competition for generation or stabilization of syn-
apses at the level of individual neurons.
Cortical neurons in Efnb3-/- mice do not display a synaptic density phenotype, but exhibit
reduced synapse density when co-cultured with wild-type neurons (McClelland et al., 2010). These
findings suggested the surprising possibility that eB3 might direct a competition between adjacent
cells to regulate synaptic density. We find that cell-cell differences in eB3 levels in two neuron micro-
islands regulate the distribution of synaptic contacts but not total synapse number. Thus, we pro-
pose that eB3 functions as a signal that allows cells to compete with one another for pre-synaptic
contacts. The absence of a synaptic density phenotype in Efnb3-/- mice is consistent with this model
since without eB3 expressed there can be no competition. Also consistent with the model is the find-
ing that in eB3 MADM mice the relative levels of eB3 regulate dendritic spine density in CTIP2 + layer
5 and 6 pyramidal neurons, which express higher levels of eB3 than neighboring SATB2 +/CTIP2 -
cells. Our findings suggest that eB3 defines a new class of proteins that regulate an underappreci-
ated aspect of synapse development: the specification of synapse number in relation to neighboring
cells.
For what does eB3 compete? The finding that blockade of ephrin-B-EphB interaction rescues syn-
apse density following eB3 knockdown suggests that eB3 likely competes for EphB-expressing axo-
nal contacts and is consistent with the finding that EphB2 can be localized both pre- and post-
synaptically in cortex (Bouvier et al., 2008). However, it is possible that other Ephs, such as EphA4
may also function as pre-synaptic ligands, or that cis interactions between eB3 and EphB2 may be
involved (Antion et al., 2010; Takemoto et al., 2002; Yokoyama et al., 2001). Importantly, treat-
ment of control cultures with unclustered EphB2 ectodomain to block ephrin-B-EphB interactions
does not alter synapse density, suggesting that it does not directly affect synapse development. In
contrast, EphB2 ectodomain fully rescued synapse density following eB3 knockdown (Figure 4 and
Figure 4—figure supplement 2). Together, these data suggest that blockade of ephrin-B-EphB
interaction does not increase the intrinsic ability of neurons to form synapses following eB3 knock-
down, but rather nullifies the competitive advantage of surrounding eB3-expressing
cells (McClelland et al., 2010). Together with data showing that EphB2 is required for eB3-mediated
pre-synaptic differentiation (McClelland et al., 2010), the simplest model suggested by our data is
that eB3 enables neurons to compete for EphB2-expressing axons.
Figure 8 continued
Source data 1. Ephrin-B3 regulates local cell-cell differences in synapse density in MADM cultures.
DOI: https://doi.org/10.7554/eLife.41563.027
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Figure 9. Control of synapse number by ephrin-B3 does not require activity. (a and b) Representative image fields and corresponding masks used for
analysis from control (a) and heterogenotypic (b) DIV11 MADM cultures treated with TTX (1 mm) from DIV3-11. Scale bar, 20 mm. (c and d) Scatter plots
in which each point represents the density of vGlut1 + synapses contacting tdTomato+ (y axis) and EGFP+ (x axis) neurons in a single image field. The
red point in each graph represents the average of all data points. The proportion of fields in which tdTomato + neurons received a higher fraction of
local synaptic contacts than EGFP + neurons is significantly higher in heterogenotypic cultures than control cultures (control, n = 166 fields;
heterogenotypic, n = 135 fields; p=0.0036, Fisher’s exact test).
DOI: https://doi.org/10.7554/eLife.41563.028
The following source data is available for figure 9:
Source data 1. Control of synapse number by ephrin-B3 does not require activity.
DOI: https://doi.org/10.7554/eLife.41563.029
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It is unlikely that other ephrin-B family members function in a similar fashion to ephrin-B3. Loss of
function experiments in cortical neurons have demonstrated that members of the ephrin-B family
have non-redundant roles in synapse development. Ephrin-B3 functions post-synaptically, while eph-
rin-B1 and ephrin-B2 have specific pre-synaptic functions (McClelland et al., 2010:
McClelland et al., 2009). These differences likely arise in part from different subcellular localization
of the three ephrin-Bs. In addition, there are important differences in how ephrin-B3 signals that
likely mediate its ability to control the competition for excitatory synapses. Ephrin-B3, but not eph-
rin-B1 or ephrin-B2, contains an Erk-binding D domain that is required for regulation of synapse den-
sity (Hruska et al., 2015). In addition, eB3 contains a perfect MAPK consensus sequence centered
on serine 332 that is absent in ephrin-B1 and ephrin-B2 (Hruska et al., 2015). Phosphorylation of
serine 332 is dependent on Erk-MAPK signaling and negatively regulates a direct interaction
between eB3 and PSD-95. The eB3-PSD-95 interaction stabilizes PSD-95 at synaptic sites and
appears to be crucial for eB3 to regulate synapse number (Hruska et al., 2015). Thus, within the
ephrin-B family, ephrin-B3 has unique signaling motifs and protein interactions that likely enable
post-synaptic eB3 to controlling synapse development. Further work will be needed to determine
whether these specific signaling mechanisms mediate the molecular competition for synapses.
Though other synaptogenic factors have not been studied in a system where competitive interac-
tions can be isolated, there is evidence that proteins such as Neuroligin-1 (NLGN1) and Trk receptor
tyrosine kinases, which have strong knockdown phenotypes but fail to display clear synaptogenesis
defects in knockout mice, and may also determine synapse number in a competitive fashion
(English et al., 2012; Joo et al., 2014; Kwon et al., 2012; Varoqueaux et al., 2006). Despite the
lack of a decrease in overall synapse number in NLGN1 knockout (KO) mice, it was found that
NLGN1 specifically promotes the formation of thalamocortical synapses by interacting with the
astrocyte-secreted protein Hevin, which bridges NLGN1 with pre-synaptic neurexin-1a (Singh et al.,
2016). NLGN1 KO mice exhibit no change in the overall density of synapses, but a decrease in the
number of thalamocortical synapses, suggesting that other sources of synaptic input to cortex com-
pensate for the loss of thalamocortical connections (Singh et al., 2016). This raises the intriguing
possibility that distinct populations of axons may compete with one another for post-synaptic tar-
gets. Determination of whether NLGN1 and Trk receptors mediate a direct competition or regulate
the ability of neurons to establish synaptic contacts will require use of a simplified system similar to
microislands. Future studies should investigate whether these proteins are also members of a class
of trans-synaptic molecules that function to define the distribution of synapses between neighboring
neurons.
Early in development, activity-independent molecular cues such as trans-synaptic adhesion mole-
cules establish the initial patterning of synapses, after which neuronal activity plays a key role in refin-
ing connectivity while maintaining the proper density of synaptic inputs (Dalva et al., 2007;
Flavell et al., 2006; Katz and Shatz, 1996). Our results suggest that the density of synapses onto
each neuron can be tuned in relation to its neighbors early in development by competition mediated
by eB3. This competition persists in the absence of action potential-driven neuronal activity, suggest-
ing that eB3 may function in an activity-independent pathway. Our findings suggest that while neu-
rons possess activity-dependent mechanisms that regulate the input-output relationship of neurons
(Turrigiano, 2012), molecular cues can also set the density of excitatory inputs. Ephrin-B3-depen-
dent regulation of synapse density appears to be one such mechanism. It is possible that synapse
density and connectivity established by eB3 represents a first step in generating specific patterns of
connections which are later refined by activity-dependent competition. Since the eB3-PSD-95 inter-
action is required for control of synapse number by eB3 (Hruska et al., 2015), one possibility is that
eB3 may stabilize nascent contacts by recruiting PSD-95 prior to activity-dependent synapse refine-
ment. Interestingly, another trans-synaptic adhesion protein, N-Cadherin, was recently found to be
involved in an activity-dependent inter-spine competition that appears to be important for synaptic
pruning (Bian et al., 2015). Thus, distinct trans-synaptic interactions may be involved in different
stages of synapse development and refinement.
In mammalian cortex, neighboring pyramidal neurons exhibit a low connection probability (CP)
on average (CP < 0.1). Yet within these sparsely connected circuits, subpopulations of neurons
exhibit connection probabilities much higher than what would be expected by chance, with an over-
representation of reciprocal connections (Brown and Hestrin, 2009; Song et al., 2005). These pat-
terns of connections cannot be explained by patterns of axonal growth, as the axon of each neuron
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is thought to promiscuously contact the dendrites of all neighboring neurons (Brown and Hestrin,
2009; Kalisman et al., 2005; Kasthuri et al., 2015). Together, these observations suggest that the
decision to accept or reject a potential synaptic contact is local, occurring at the site of axo-dendritic
contact.
Here, we find that a cell-cell competition mediated by a trans-synaptic organizing protein, eB3,
can control the relative distribution of synaptic contacts between neighboring neurons, without alter-
ing the overall number of synapses (Figure 3). By generating a trans-cellular competition, eB3 may
act as a cue that enables neurons to ‘interview’ potential synaptic partners with appropriate pre-syn-
aptic markers (EphBs). Importantly, expression levels of eB3 and gene dosage of eB3 is correlated
with synapse number (Figure 6) (McClelland et al., 2010). Thus, eB3-dependent competition could
allow neurons to fine tune the number of synapses they receive. Consistent with this model, Efnb3+/-
neurons within eB3 MADM mice exhibited spine densities in between that of WT and Efnb3-/- neu-
rons in the same mice. Interestingly, the difference between WT and Efnb3+/- neurons reached sig-
nificance, while the difference between Efnb3+/- neurons and Efnb3-/- neurons did not. Given the
large effects seen in heterogenotypic cultures or following eB3 knockdown (McClelland et al.,
2010), these findings are somewhat surprising and, suggest either that there may be some compen-
sation in the MADM mice, or that the presence of many unlabeled Efnb3+/- neurons in MADM eB3
mice reduces the impact of the loss of eB3. Regardless, variations in the level of eB3 appear to regu-
late the density of excitatory synaptic connections cortical neurons receive.
Ephrin-B3-EphB2-mediated competition appears ideally suited to generate a key feature of corti-
cal connectivity: highly interconnected sub-populations of cells within an overall sparsely connected
network, a feature that may be crucial for optimizing the storage capacity of cortical networks (Bru-
nel, 2016). One example of this type of connectivity is in visual cortex, where the connection proba-
bility between neighboring cells differs between subpopulations of layer five neurons (Brown and
Hestrin, 2009). Subcortically projecting neurons (corticotectal and corticostriatal) receive a high den-
sity of inputs from callosally projecting and corticostriatal neurons, respectively. In contrast, the local
inputs onto neighboring callosally projecting layer 5 cells are relatively sparse. In light of the finding
that CTIP2+, subcortically projecting neurons express higher levels of Efnb3 mRNA than SATB2+/
CTIP2 -, callosally projecting neurons, one function of eB3-dependent competition may be to
increase the relative density of specific types of inputs to subcortically projecting cells compared to
neighboring callosally projecting cells. Consistent with previous work (McClelland et al., 2010), we
also observed considerable variability in eB3 expression between individual CTIP2 + cells, suggest-
ing that eB3 may serve to finely tune the connectivity of individual neurons within this population.
More work will be needed to determine whether loss of eB3 impacts these specific types of circuit
organization.
Materials and methods
Key resources table
Reagent type
(species) or
resource Designation
Source or
reference Identifiers
Additional
information
Genetic
reagent
(Mus musculus)
ephrin-B3
knockout
(and WT
littermates)
Yokoyama et al.,
2001, Hruska et al.,
2015, Antion et al.,
2010.
RRID:
MGI:3026744
Genetic
reagent
(M. musculus)
MADM-11 TG,
eB3+/MADM-
11 TG,
eB3- (founder
line)
This paper. Progenitor:
MADM-11 TG/TG
(Hippenmeyer
et al., 2010),
RRID: IMSR_
JAX:013749
Genetic
reagent
(M. musculus)
MADM-11
GT/GT;
Emx1-Cre
Hippenmeyer et al.,
2010, Beattie et al.,
2017.
Progenitor:
IMSR_JAX:005628
Continued on next page
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Continued
Reagent type
(species) or
resource Designation
Source or
reference Identifiers
Additional
information
Genetic
reagent
(M. musculus)
MADM-11
GT/GT;
Nestin-spCre
Hippenmeyer
et al., 2010.
Strain,
strain
background
(Rattus
norvegicus
domesticus)
Long
Evans Rat
Charles River Strain code:
006: RRID:
RGD_2308852
Aantibody Rabbit
polyclonal
anti-GFP
Thermo
Fisher Scientific
A6455, RRID:
AB_221570
(1:2500)
Aantibody Mouse
monoclonal
anti-PSD-95
NeuroMab
(clone 28/43)
Cat. # 75–028,
RRID:AB_
2292909
(1:500)
Antibody Guinea pig
polyclonal
anti-vGlut1
Millipore Cat. #AB5905,
RRID:AB_
2301751
(1:5000)
Antibody Rabbit
polyclonal
anti-RFP
Rockland
antibodies
Cat. # 600-
401-379,
RRID:AB_
2209751
(1:500)
Antibody Chicken
polyclonal
anti-GFP
Abcam Cat. # ab13970,
RRID:AB_
300798
(1:500)
Antibody Rat monoclonal
anti-CTIP2
Abcam Cat. # ab18465,
RRID:AB_
10015215
(1:500)
Antibody Mouse
monoclonal
anti-SATB2
Abcam Cat. # ab51502,
RRID:AB_
882455
(1:500)
Antibody Donkey
polyclonal
anti-rabbit
Dylight 488
Abcam Cat. # ab96919,
RRID:AB_
10679362
(1:500)
Antibody Donkey
polyclonal
anti-chicken
Dylight 488
Jackson Immunoresearch Cat. # ab96947,
RRID:AB_
10681017
(1:500)
Antibody Donkey
polyclonal
anti-rabbit
Alexafluor 594
Jackson Immunoresearch Cat. # 711-
585-152,
RRID:AB_
2340621
(1:500)
Antibody Donkey
polyclonal
anti-rat 647
Jackson Immunoresearch Cat. # 712-
605-153,
RRID:AB_
2340694
(1:500)
Antibody Goat
polyclonal
anti-mouse
ATTO 425
Rockland
antibodies
Cat. # 611-
151-122,
RRID:AB_
10893217
(1:250)
Antibody Donkey
polyclonal
anti-guinea
pig Dylight 649
Jackson Immunoresearch Cat. # 706-
605-148,
RRID:AB_
2340476
(1:500)
Continued on next page
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Continued
Reagent type
(species) or
resource Designation
Source or
reference Identifiers
Additional
information
Recombinant
DNA reagent
pFUGW-
tdTomato_
H1-eB3.2
(plasmid)
Hruska et al., 2015. Progenitor:
pFUGW
(RRID:Addgene_
14883); pSuper.
Recombinant
DNA reagent
pFUGW-
tdTomato_
H1-pSuper
(plasmid)
Hruska et al., 2015. Progenitor:
pFUGW
(RRID:Addgene_
14883), pSuper.
Recombinant
DNA reagent
pSuper
(plasmid)
Hruska et al.,
2015, McClelland
et al., 2010.
Recombinant
DNA reagent
eB3.2
shRNA
(plasmid)
Hruska et al.,
2015, McClelland
et al., 2010.
pSuper
Recombinant
DNA reagent
pFUGW
(plasmid)
Hruska et al.,
2015, McClelland
et al., 2010.
RRID:Addgene_
14883
Recombinant
DNA reagent
pLL3.7
(plasmid)
Addgene RRID:Addgene_
11795
Recombinant
DNA reagent
ephrin-B3
shRNA
lentivirus
Penn Vector Core
(University of
Pennsylvania)
Progenitor:
pLL3.7 vector
(RRID:Addgene_
11795)
Peptide,
recombinant
protein
Recombinant
human EphB2
Fc chimera
R and D
systems
Cat. #
5189-B2
Peptide,
recombinant
protein
Recombinant
Fc control
fragment
R and D
systems
110-HG-100
Commercial
assay or kit
RNAscope
fluorescent
multiplex kit
Advanced
Cell Diagnostics
320850
Commercial
assay or kit
RNAscope
probe- Mm-
Bcl11b (CTIP2)
Advanced
Cell Diagnostics
Cat. #
413271-C3
Commercial
assay or kit
RNAscope
probe- Mm-
Satb2-C2
Advanced Cell
Diagnostics
Cat. #
413261-C2
Commercial
assay or kit
RNAscope
probe- Mm-
Efnb3
Advanced Cell
Diagnostics
Cat. #
526771
Chemical
compound,
drug
Tetrodotoxin
(TTX)
Tocris Cat. #
1078
Software,
algorithm
NIH ImageJ McClelland et al.,
2009, Hruska et al.,
2015.
RRID:
SCR_003070
Constructs used for transfection
We used GATEWAY technology (Fisher Scientific) to generate constructs that lead to simultaneous
expression of PSD-95-GFP, tdTomato and either ephrin-B3 shRNA or control pSuper cassette
(pFUGW-tdTomato-eB3.2 and pFUGW-tdTomato-pSuper) for use in microisland cultures. The pro-
moters used are from human ubiquitin (hUb), synapsin (Syn), and H1, respectively. To do this, the
existing pFUGW vector was converted into a GATEWAY destination vector using the Gateway vec-
tor conversion system kit (Fisher Scientific). First, we removed GFP (EGFP) downstream of the hUb
promoter from the original pFUGW by cutting with XbaI (New England Biolabs) and subsequently
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blunted the sites with Klenow fragment (New England Biolabs). Then in place of GFP we cloned
Reading Frame A cassette (RfA, Fisher Scientific) that contains 5’ attR1 and 3’ attR2 sites, with chlor-
amphenicol and ccdB genes, thus rendering pFUGW Gateway compatible. Finally, to generate the
expression plasmid containing PSD-95-GFP, tdTomato and ephrin-B3 shRNA with their respective
promoters, we performed 4-fragment Gateway LR recombination by combining the pFUGW-Desti-
nation vector and four pDONR 221 entry plasmids containing following fragments: 1) 5’ attL1_PSD-
95-GFP_attR5 3’; 2) 5’ attL5_BGH_PA_attL4 3’; 3) 5’ attR4_SynPro_tdTomato_SV40PA_attR3r 3’ and
4) 5’ attL3_H1_ephrin-B3shRNA_attL2 3’ or 5’ attL3_pSuper cassette_attL2 3’. The resulting pFUGW
expression plasmids contained PSD-95-GFP under control of the hUb promoter, tdTomato under
control of the synapsin promoter and ephrin-B3 shRNA or pSuper cassette under control of the H1
promoter. For complex neuronal culture experiments, neurons were transfected with pFUGW to
express GFP together with eB3.2 shRNA or pSuper control vectors (Hruska et al., 2015 ).
Generation of ephrin-B3 MADM mice
MADM-11 mice containing the TG and GT knock-in cassettes to the Hipp11 locus on chromosome
11 (Hippenmeyer et al., 2010) were obtained from Dr. Simon Hippenmeyer. MADM-11TG/TG mice
were crossed to mice heterozygous for an ephrin-B3 null allele (Yokoyama et al., 2001) to obtain
MADM-11 TG, Efnb3++ MADM-11 TG, Efnb3- (founder line) mice. MADM-11GT/GT mice were
crossed to either an Emx1-Cre line, or an spNestin-Cre (Nestin-CreERT2) line where CRE recombi-
nase is active in a sparse, random subset of neural progenitor cells in the absence of tamoxifen
(Hippenmeyer et al., 2010), to obtain MADM-11GT/GT; Emx1-Cre and MADM-11GT/GT; Nestin-spCre
lines, respectively. These lines were crossed to the founder line, yielding MADM-11GT/TG, Efnb3+/-;
Emx1-Cre+/- (eB3 MADM; Emx1-Cre) or MADM-11GT/TG,Efnb3+/-; Nestin-spCre+/- (eB3 MADM; Nes-
tin-spCre) mice.
Complex neuronal cultures
E17-18 Long Evans rat cortical neurons were dissociated and cultured as described previously
(McClelland et al., 2010). Briefly, neurons were cultured in 24 well plates at a density of 150,000
cells/well in Neurobasal media (Fisher Scientific) supplemented with B27 supplement (Fisher Scien-
tific), glutamine (Sigma), and penicillin/streptomycin (Sigma). Coverslips (12 mm Bellco Glass) were
coated with poly-D-lysine and laminin (BD Biosciences). For transfections at DIV0, cells were dissoci-
ated in OptiMEM (Fisher Scientific) and transfected using Lipofectamine (Fisher Scientific) immedi-
ately before plating.
MADM neuronal cultures
Neurons were dissociated from P0-1 Emx1-Cre control and eB3 MADM mice. Labeled neurons were
then isolated by FACS sorting, and EGFP + and tdTomato + cells were plated at a 1:1 ratio in 48
well plates at a total density of approximately 30,000 cells/well. Neurons were cultured in Neuro-
basal media (Fisher Scientific) supplemented with B27 supplement (Fisher Scientific), glutamine
(Sigma), and penicillin/streptomycin (Sigma). Coverslips (5 mm Bellco Glass) were coated with poly-
D-lysine and laminin (BD Biosciences). From DIV3-11, neurons were treated with culture media con-
taining TTX (1 mm final concentration) or nothing added. Cultures were also treated every 48 hr with
mitosis inhibitors uridine (10 mm) and 5-fluoro-2-deoxyuridine (0.1 mm) to prevent any astrocytes
present from dividing.
Microisland cultures
Microislands were generated from E17-18 dissociated rat cortical neurons using a protocol modified
from Allen (2006). Coverslips (12 mm Bellco Glass) were placed in 24-well plates, then 10–30 ml of a
0.15% agarose solution was applied to each coverslip and allowed to air dry. 3 drops of heated par-
affin wax (Aldrich) were applied to the edges of each coverslip, and plates were stored at 4 ˚C until
further use. On the day neurons were plated, an atomizer was used to spray droplets of poly-D-
lysine/laminin solution into the pre-prepared 24 well plates described above. After air-drying, the
plates were washed once with distilled water. 500 ul of supplemented Neurobasal media (see above)
was added to each well and the plates were placed in a humidified incubator maintained at 5%
CO2˚C and 37˚C. Prior to plating, neurons were transfected by electroporation using an Amaxa
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Nucleofector (Lonza Walkerrsville). 5 million neurons per transfection condition were suspended in
100 ul of P3 primary cell solution (Lonza cat. no. PBP3-02250) and transfected with 3 mg of the
appropriate DNA construct. Immediately after transfection, 900 ml of pre-warmed, supplemented
Neurobasal medium was added to the transfected cells, which were subsequently plated in the pre-
warmed 24 well plates described above at a density of 15,000–40,000 cells/well. On the same day as
transfection, separate ‘feeder’ layers of neurons were prepared by coating 24 well plates (without
coverslips) with poly-D-lysine/Laminin solution and plating 150,000 cells/well. The following day, the
coverslips containing the transfected neurons were placed onto the feeder neurons (wax droplets
facing down). Cultures were maintained in this manner in a humidified incubator maintained at 5%
CO2˚C and 37˚C.
Lentiviral transduction
ephrin-B3 shRNA target sequence was cloned into lentilox pLL3.7 GFP packaging plasmid and the
high titer (1010) lentivirus was produced by Penn Vector Core at the University of Pennsylvania. Neu-
rons were transduced with control or eB3 shRNA lentivirus immediately after dissociation by adding
1–5 ml of high titer particles to the neuronal suspension containing 5–10 million neurons. After incu-
bation at 37˚C for 2 hr, neurons were plated on coverslips containing PDL/laminin spotted microdots
and placed into 37˚C/5% CO2 incubator for the indicated amount of time before synapse density
analysis was performed.
Unclustered EphB2 ectodomain treatment
Cultured neurons in 24 well plates were treated with unclustered EphB2-Fc or control Fc fragment (R
and D Biosystems) once every 48 hr starting from DIV3 to DIV10 (complex cultures) or DIV21 (micro-
island cultures). To test the dose-dependency of EphB2-Fc treatment, separate treatment conditions
of 2.5 ng/well (5 ng/ml), 25 ng/well (50 ng/ml), and 250 ng/well (500 ng/ml) were used. To determine
whether neurons expressing ephrin-B3 shRNA bound less EphB2-Fc, DIV10 control and ephrin-B3
shRNA-expressing neurons were treated with 500 ng/ml with unclustered EphB2-Fc for 45 min, then
fixed in 4% PFA with 2% sucrose for immunocytochemistry.
Immunoprecipitation and western blots following EphB2 ectodomain
treatment
DIV8 cortical neurons were treated with control Fc fragment, 500 ng/ml pre-clustered EphB2-ecto-
domain, or 500 ng/ml unclustered EphB2-ectodomain for 45 min. Neurons were then lysed in 500 ml
of lysis buffer (50 mM Tris, 140 mM NaCl, 0.5% NP40, pH7.4) containing general protease inhibitor
cocktail (Sigma) and 1 mM PMSF and phosphatase inhibitors (2 mM EGTA (Sigma), 50 mM NaF
(Sigma), 1 mM Na3VO4 (Sigma), 10 mM Na4O7P2.10H2O (Sigma) and 0.1 mM H24Mo7N6O24.4H2H
(Sigma). Insoluble material was removed by centrifuging at 10,000 g for 20 min at 4˚C and the
remaining supernatant was immunoprecipitated with a rabbit anti-ephrin-B3 antibody (Thermo) for 4
hr at 4˚C. Then 20 ml of protein G beads (blocked in 1% BSA in lysis buffer) was added to the super-
natant and incubated by head over tail rotation for an additional hour at 4˚C. Beads were washed
three times with lysis buffer and once with Tris-buffered saline containing 10 mM NaF, 1 mM
Na3VO4 with protease inhibitor cocktail (Sigma) and 1 mM PMSF. Proteins were subsequently eluted
from the beads by boiling in 4x SDS sample buffer for 5 min. Eluted proteins were separated on
SDS-PAGE gels, transferred to PVDF membrane (Millipore), blocked with 1% BSA, labeled with anti
ephrin-B3 (Thermo) and anti phospho-ephrin-B (Cell Signaling) antibodies and HRP-conjugated sec-
ondary antibodies, and visualized with Western Lightning Plus-ECL (PerkinElmer, Waltham, MA).
Immunocytotochemistry
Cultured neurons were fixed in paraformaldehyde (PFA) solution containing 4% PFA and 2% sucrose
for 8 min at room temperature, washed 3X in PBS, then blocked for 1 hr at room temperature in a
solution containing 1% ovalbumin (Sigma)/0.2% cold-water fish scale gelatin (Sigma) and 0.1% sapo-
nin. Primary antibody incubations were performed at 4 ˚C overnight. The antibodies used were as
follows: rabbit anti-GFP (1:2500, Fisher Scientific), mouse anti-PSD-95 (1:500, NeuroMab), guinea
pig anti-vGlut1 (1:5000, Millipore), rabbit anti-RFP (1:500, Rockland antibodies), and chicken anti-
GFP (1:500, Abcam). Secondary antibody incubations were performed at room temperature for 45
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min. The secondary antibodies were used at a concentration of 1:250–500 and were as follows: don-
key anti-rabbit Dylight 488 (Abcam), donkey anti-guinea pig Dylight 649 (Jackson Immunoresearch),
and goat anti-mouse ATTO 425 (Rockland Immunochemicals). Coverslips were mounted with Aqua-
mount aqueous media (Lerner Laboratories).
Immunohistochemistry
In order to achieve rapid fixation, 300 mm acute brain slices from postnatal day (P)18–21 Nestin-
spCre control and eB3 MADM-11 mice were cut, maintained for two hours in artificial cerebrospinal
fluid (ACSF), then fixed overnight at 4 ˚C by rapid submersion in freshly prepared 4% PFA. Brain sec-
tions were then washed three times in 1X PBS and submerged in 30% Sucrose/PBS overnight. The
sections were then re-sectioned at 40 mm. For immunostaining, sections were permeabilized for 25
min in 0.5% Triton X-100, then blocked overnight at 4 ˚C in blocking solution containing 10% FBS,
1% BSA, and 0.2% Triton X-100. The following day, sections were incubated with primary antibodies
in blocking solution overnight at 4 ˚C. The following day, sections were incubated for 2 hr at room
temperature with the appropriate secondary antibodies. The primary antibodies used were as fol-
lows: chicken anti-GFP (1:500, Abcam), rabbit anti-RFP (1:500, Rockland antibodies), rat anti-CTIP2
(1:500, Abcam), mouse anti-Satb2 (1:500, Abcam). The secondary antibodies used were as follows:
donkey anti-chicken dylight 488 (1:500, Abcam), donkey anti-rabbit Alexafluor 594 (1:500, Jackson
Immunoresearch), donkey anti-rat Alexafluor 647 (1:500, Jackson Immunoresearch), and goat anti-
mouse ATTO 425 (1:250, Rockland antibodies).
RNAscope ISH
P28 WT and Efnb3-/- mice were trans-cardially with PBS followed by 4% PFA. Brains were post-fixed
for 24 hr at 4˚ C, then washed 3X with PBS and submerged in 30% sucrose/PBS for 48 hr at 4˚C.
Brains were then frozen in OCT medium, cryosectioned at 20 mm, and mounted on Superfrost slides
(Fisher Scientific). Slides were stored at  80 ˚C until use, then baked at 50 ˚C for one hour prior to
initiating the RNAscope protocol. Pre-treatment of tissue sections and RNAscope ISH was carried
out according to manufacturer protocols (Advanced Cell Diagnostics, Inc) using the RNAscope fluo-
rescent multiplex kit (Cat No. 320850) with CTIP2 (Cat No. 413271-C3), SATB2 (Cat No. 413261-C2)
and eB3 (Cat No. 526771) probes.
Imaging and analysis
Complex neuronal cultures and microislands
Images were aquired on a Leica TCS SP5 confocal scanning microscope (Leica Microsystems, Man-
nheim, Germany). Stacks of 6–8 images taken at 0.3 mm intervals were acquired with a 63X oil
immersion objective (Leica) with a 1.7X-1.9X zoom. Maximum intensity projections of the image
stacks were analyzed to calculate synapse or puncta density using custom ImageJ macros as
described previously (McClelland et al., 2010). Briefly, each channel for each image was thresholded
and converted to a binary image, and vGlut1, and PSD-95 puncta were defined as 0.5–7.5 mm of
continuous pixels. For unclustered EphB2 ectodomain control experiments, puncta were defined as
having at least one pixel overlap with GFP-labeled dendrites. Synapse or puncta density was calcu-
lated as the density of colocalized puncta (with > 1 pixel overlap) from a region of at least 50 mm of
dendrite per cell. In two-neuron microislands, the number of colocalized PSD-95-GFP/vGlut1 puncta
was used to calculate synapse density in transfected neurons. For untransfected neurons, synapse
density was calculated by subtracting the number of colocalized PSD-95-GFP/vGlut1 puncta from
the number of PSD-95/vGlut1 puncta.
MADM cultures
MADM cultures were imaged on a Leica TCS SP5 confocal scanning microscope (Leica Microsystems,
Manheim, Germany). The automated imaging feature in Leica application suite was used to sequen-
tially image the entirety of each coverslip with a 63X oil immersion objective (Leica) and 1.7X zoom.
Image fields containing EGFP + and tdTomato + cells were then selected for analysis. We confirmed
that the numbers of tdTomato + and EGFP + neurons in each culture did not significantly differ by
selecting 6–10 random image fields form each experiment and counting the number of EGFP + and
tdTomato + cell bodies in each image. The numbers of EGFP + and tdTomato + cells did not
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significantly differ in control (n = 26 fields, 2.46 ± 0.347 red vs. 2.231 ± 0.29 green cells, t(50)= 0.51,
p=0.6123, two-tailed Student’s t-test) or heterogenotypic (n = 25 fields, 2.44 ± 0.252 red vs.
3.16 ± 0.496 green, t(48)= 1.295, p=0.2016, two-tailed Student’s t-test) cultures. Fields with exceed-
ingly high cell density were excluded due to the difficulty of accurately assigning synaptic contacts
to cells. In addition, fields containing cells with non-neuronal morphology were excluded. Analysis
was carried out using custom ImageJ macros. Briefly, maximum intensity projections for each chan-
nel for each image were generated, thresholded and converted to binary images. Axons were
removed from tdTomato and EGFP channels using the particle analysis tool in ImageJ. vGlut1
puncta were defined as 0.5–7.5 mm of continuous pixels. An ImageJ macro was used to assess the
overlap of each vGlut1 puncta with tdTomato and EGFP channels, assigning each puncta to the
channel that contained the largest area of overlap with the vGlut1 puncta. Puncta that overlapped
equally with each channel were categorized as ‘unknown’, and manually assigned when possible.
Synapse density was then calculated on a per image basis as density per unit area of vGlut1 puncta
assigned to tdTomato + and EGFP + cells.
Dendritic spine imaging and quantification
MADM brain sections were imaged on a Leica TCS SP5 confocal scanning microscope (Leica Micro-
systems, Mannheim, Germany). Stacks of 5–15 images taken at 0.6–2 mm intervals were acquired
with a 63X oil immersion objective (Leica) with 1.7–2.4X zoom. For each cell, dendritic spines were
counted on a segment of apical dendrite at least 40 mm in length. Dendrite width was measured by
creating a mask of each dendrite, manually erasing dendritic protrusions from the image, then calcu-
lating the average width of the dendrite by dividing the total area of the dendrite by its length.
RNAscope ISH imaging and quantification
WT and Efnb3-/- brain sections were imaged on a Leica TCS SP8 confocal scanning microscope (Leica
Microsystems, Mannheim, Germany). 10–18 mm stacks (approximately the width of a single nucleus)
were acquired at 2 mm intervals with a 63X oil immersion objective and 1.7X zoom. To avoid experi-
menter bias, fields of view were chosen by visualizing CTIP2 and DAPI signals to identify subgranular
layers of cortex, without looking at the eB3 channel. Images were analyzed using custom ImageJ
macros. Briefly, maximum projections of each channel were thresholded after applying gaussian blur
and background subtraction (same threshold for all RNAscope probes), and nuclei were automati-
cally identified and selected as ROIs. RNAscope puncta in the size range of 4–100 pixels were
selected for further analysis. Each ROI corresponding to a nucleus was automatically scored as ‘posi-
tive’ for CTIP2 and/or SATB2 if it contained at least 10 puncta. Ephrin-B3 probe puncta within each
of these ROIs were then automatically counted.
Statistical analyses
Data plotted on bar graphs are expressed as the mean ± SEM. Sample sizes were not formally calcu-
lated but are consistent with the standards in field. Statistical differences were determined using
one-way ANOVA followed by Tukey’s HSD post-hoc test, one sample t-test, Fisher’s exact test, or
Student’s t-test as indicated. P values of less than 0.05 were considered statistically significant, and
data were pooled from a minimum of three independent experiments unless otherwise indicated.
Statistical tests were done on a per cell basis unless otherwise noted. Experimental groups were
defined by treatment/transfection condition or genotype. No outlying data points were removed
from analysis. Analysis and data aquisition was done with the experimenter blinded to condition
with the exception of MADM culture and RNAscope experiments, for which the analysis was auto-
mated. For each experiment, cell morphology was examined and cells that exhibited signs of poor
health were excluded.
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